Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease ; volume:3 ; number:1 ; day:24 ; month:3 ; year:2015 ; pages:1-11 ; date:12.2015
Acta Neuropathologica Communications ; 3, Heft 1 (24.3.2015), 1-11, 12.2015

Creator: Pooler, Amy M.
Polydoro, Manuela
Maury, Eduardo A.
Nicholls, Samantha B.
Reddy, Snigdha M.
Wegmann, Susanne
William, Christopher
Saqran, Lubna
Cagsal-Getkin, Ozge
Pitstick, Rose
Beier, David R.
Carlson, George A.
Spires-Jones, Tara L.
Hyman, Bradley T.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-015-0199-x

URN: urn:nbn:de:101:1-2021081920432229000700

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pooler, Amy M.
Polydoro, Manuela
Maury, Eduardo A.
Nicholls, Samantha B.
Reddy, Snigdha M.
Wegmann, Susanne
William, Christopher
Saqran, Lubna
Cagsal-Getkin, Ozge
Pitstick, Rose
Beier, David R.
Carlson, George A.
Spires-Jones, Tara L.
Hyman, Bradley T.
SpringerLink (Online service)

Other Objects (12)

Propagation of Tau pathology in Alzheimer disease

Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Correction: Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Propagation of Tau pathology in Alzheimer disease

Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Correction: Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Propagation of Tau pathology in Alzheimer disease

Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Correction: Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Propagation of Tau pathology in Alzheimer disease

Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Correction: Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Propagation of Tau pathology in Alzheimer disease

Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Correction: Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Propagation of Tau pathology in Alzheimer disease

Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Correction: Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Related objects

Reset password